Creation of Novel Gene Therapy Delivery Technology
Filed with ASX · · 4 pages · English
PYC Therapeutics Limited on 6ix
Story so far
Earlier from PYC Therapeutics
- Appendix 4E Preliminary Final Report
- Executive re-structure across global operations
- Shareholder Update - Forward View 2020 Milestones
- June 2020 Quarterly Activity Report and Cashflow
- Successful Dose Response & Toxicity Studies in Lead Program
Later from PYC Therapeutics
- Second Potential Blockbuster Drug Added to PYCs Pipeline
- PYCs Lead Drug Effective in Patient Derived Models Tested
- New Drug for Substantial Unmet Need Added to Pipeline
- PYC Equity Raising to Raise up to $55 Million
- PYC Business and Equity Raising Presentation
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics